These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 11937086)
1. Is the 5-HT(7) receptor involved in the pathogenesis and prophylactic treatment of migraine? Terrón JA Eur J Pharmacol; 2002 Mar; 439(1-3):1-11. PubMed ID: 11937086 [TBL] [Abstract][Full Text] [Related]
4. An introduction to migraine: from ancient treatment to functional pharmacology and antimigraine therapy. Villalón CM; Centurión D; Valdivia LF; De Vries P; Saxena PR Proc West Pharmacol Soc; 2002; 45():199-210. PubMed ID: 12434581 [TBL] [Abstract][Full Text] [Related]
5. Selective inhibition of 5-HT7 receptor reduces CGRP release in an experimental model for migraine. Wang X; Fang Y; Liang J; Yin Z; Miao J; Luo N Headache; 2010 Apr; 50(4):579-87. PubMed ID: 20236348 [TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical and biomolecular identification of 5-HT₇ receptor in rat vestibular nuclei. Khalmuratova R; Hah YS; Ahn SK; Jeon SY; Kim JP; Balaban CD J Vestib Res; 2010; 20(6):401-6. PubMed ID: 21248402 [TBL] [Abstract][Full Text] [Related]
7. 5-Hydroxytryptamine and its role in migraine. Lance JW Eur Neurol; 1991; 31(5):279-81. PubMed ID: 1884718 [TBL] [Abstract][Full Text] [Related]
8. Neurogenic inflammation in the context of migraine. Williamson DJ; Hargreaves RJ Microsc Res Tech; 2001 May; 53(3):167-78. PubMed ID: 11301492 [TBL] [Abstract][Full Text] [Related]
9. The selectivity of MDL 74,721 in models of neurogenic versus vascular components of migraine. Petty MA; Elands J; Johnson MP; Linnik MD; Hamel E; Moskowitz MA; Lee WS; McCarty DR; Hibert M; Baron BM Eur J Pharmacol; 1997 Oct; 336(2-3):127-36. PubMed ID: 9384224 [TBL] [Abstract][Full Text] [Related]
11. Cardiovascular responses produced by 5-hydroxytriptamine:a pharmacological update on the receptors/mechanisms involved and therapeutic implications. Villalón CM; Centurión D Naunyn Schmiedebergs Arch Pharmacol; 2007 Oct; 376(1-2):45-63. PubMed ID: 17703282 [TBL] [Abstract][Full Text] [Related]
12. 5-Hydroxytryptamine and the pathophysiology of migraine. Humphrey PP J Neurol; 1991; 238 Suppl 1():S38-44. PubMed ID: 2045830 [TBL] [Abstract][Full Text] [Related]
13. [Serotonin agonists and antagonists in migraine]. Ollat H Pathol Biol (Paris); 1992 Apr; 40(4):389-96. PubMed ID: 1353874 [TBL] [Abstract][Full Text] [Related]
14. A comparative study of amitriptyline and fluvoxamine in migraine prophylaxis. Bánk J Headache; 1994 Sep; 34(8):476-8. PubMed ID: 7960733 [TBL] [Abstract][Full Text] [Related]
15. 5-Hydroxytryptamine (5-HT) and the initiation of migraine: new perspectives. Fozard JR; Kalkman HO Naunyn Schmiedebergs Arch Pharmacol; 1994 Sep; 350(3):225-9. PubMed ID: 7824037 [TBL] [Abstract][Full Text] [Related]